These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3770531)

  • 1. Digoxin-like substance in amniotic fluid--fact or artifact?
    Greenway DC; Nanji AA
    Gynecol Obstet Invest; 1986; 22(2):108-9. PubMed ID: 3770531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Existence of a digitalis-like compound in the human fetus.
    Guédeney X; Chanez C; Scherrmann JM
    Biol Neonate; 1991; 59(3):133-8. PubMed ID: 1647221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary digoxin-like immunoreactive substance in pregnancy. Relation to urinary electrolytes.
    Friedman HS; Abramowitz I; Nguyen T; Babb B; Stern M; Farrer SM; Tricomi V
    Am J Med; 1987 Aug; 83(2):261-4. PubMed ID: 3618628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal changes in a digoxin-like immunoreactive substance.
    Seccombe DW; Pudek MR; Whitfield MF; Jacobson BE; Wittmann BK; King JF
    Pediatr Res; 1984 Nov; 18(11):1097-9. PubMed ID: 6514436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digitalislike immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients.
    Bisordi JE; Holt S
    Am J Kidney Dis; 1989 May; 13(5):396-403. PubMed ID: 2541609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-like immunoreactive substance in urine of patients with mucocutaneous lymph node syndrome (MCLS).
    Tamura H; Shimoyama S; Sunaga Y; Sakaguchi M; Kuroume T
    Angiology; 1992 Oct; 43(10):856-65. PubMed ID: 1335703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin-like immunoreactive substance and preterm labor.
    Ayhan A; Yarali H; Diker I; Urman B; Develioğlu O
    Gynecol Obstet Invest; 1990; 30(2):75-7. PubMed ID: 2245952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA; Oldfield PR; Murphy GM; Lawson AM
    Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.